Evidence map›Paper›PMID 37373909›Full record

ArticleJournal of personalized medicine2023

Machine-Learning-Based Radiomics for Classifying Glioma Grade from Magnetic Resonance Images of the Brain.

Anuj Kumar, Ashish Kumar Jha, Jai Prakash Agarwal, Manender Yadav, Suvarna Badhe, Ayushi Sahay, Sridhar Epari, Arpita Sahu, Kajari Bhattacharya, Abhishek Chatterjee and 5 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Radiomics in thyroid nodule assessment.BMC medical imaging · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anuj KumarDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.ORCID 0000-0001-9660-1510
Ashish Kumar JhaDepartment of Nuclear Medicine, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.ORCID 0000-0001-5998-3206
Jai Prakash AgarwalDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Manender YadavDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Suvarna BadheDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Ayushi SahayDepartment of Pathology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Sridhar EpariDepartment of Pathology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Arpita SahuDepartment of Radiodiagnosis, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.ORCID 0000-0003-1549-3680
Kajari BhattacharyaDepartment of Radiodiagnosis, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.ORCID 0000-0003-2917-2079
Abhishek ChatterjeeDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Balaji GaneshanInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London NW1 2BU, UK.ORCID 0000-0002-1386-0531
Venkatesh RangarajanDepartment of Nuclear Medicine, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Aliasgar MoyiadiDepartment of Neurosurgery, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.ORCID 0000-0002-4082-2004
Tejpal GuptaDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.
Jayant S GodaDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhaba National Institute, Mumbai 400012, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grading of gliomas is a piece of critical information related to prognosis and survival. Classifying glioma grade by semantic radiological features is subjective, requires multiple MRI sequences, is quite complex and clinically demanding, and can very often result in erroneous radiological diagnosis. We used a radiomics approach with machine learning classifiers to determine the grade of gliomas. Eighty-three patients with histopathologically proven gliomas underwent MRI of the brain. Whenever available, immunohistochemistry was additionally used to augment the histopathological diagnosis. Segmentation was performed manually on the T2W MR sequence using the TexRad texture analysis softwareTM, Version 3.10. Forty-two radiomics features, which included first-order features and shape features, were derived and compared between high-grade and low-grade gliomas. Features were selected by recursive feature elimination using a random forest algorithm method. The classification performance of the models was measured using accuracy, precision, recall, f1 score, and area under the curve (AUC) of the receiver operating characteristic curve. A 10-fold cross-validation was adopted to separate the training and the test data. The selected features were used to build five classifier models: support vector machine, random forest, gradient boost, naive Bayes, and AdaBoost classifiers. The random forest model performed the best, achieving an AUC of 0.81, an accuracy of 0.83, f1 score of 0.88, a recall of 0.93, and a precision of 0.85 for the test cohort. The results suggest that machine-learning-based radiomics features extracted from multiparametric MRI images can provide a non-invasive method for predicting glioma grades preoperatively. In the present study, we extracted the radiomics features from a single cross-sectional image of the T2W MRI sequence and utilized these features to build a fairly robust model to classify low-grade gliomas from high-grade gliomas (grade 4 gliomas).

Indexed as

classifiersglioma grademachine learningradiomics

Identifiers

PMID37373909
PMCPMC10305272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.